Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 May;59(5):775–782. doi: 10.1038/bjc.1989.162

The natural history of human breast cancer. The relationship between involvement of axillary lymph nodes and the initiation of distant metastases.

S Koscielny 1, M G Le 1, M Tubiana 1
PMCID: PMC2247222  PMID: 2736212

Abstract

A method has been developed for determining the mean volume of breast cancer in women at the time of the involvement of the first, second, third,... nth axillary lymph nodes. It has been found that the proportion of patients with axillary involvement as well as the number of involved nodes increase progressively with tumour size. This orderly involvement of axillary nodes is observed in all patient subsets despite a wide spread of tumour volume at the time of invasion of the axillary nodes. This makes it possible to compute for each patient or subset of patients the size of the tumour at the time of the first node involvement, a parameter which characterises the propensity for nodal involvement. A strong correlation was demonstrated between the propensity to lymphatic involvement and the probability of distant dissemination. During tumour progression the capacity for lymphatic spread is on average acquired much earlier than the capacity for haematogenous spread. For tumours of the outer quadrants, the volume at first axillary involvement is smaller than for tumours located in the inner quadrants, whereas the tumour volumes at the time of distant metastatic initiation are equal for the two tumour sites. The discrepancy between these two observations shows that axillary involvement, while being a good index of the propensity of the tumour cells to acquire the capacity for distant spread, is not the cause of this spread. From a clinical point of view, these data show that the prognostic significance of axillary involvement can be further increased by taking into account the size of the tumour. The data suggest that there is a continuum from slow growing disease with late axillary involvement and late distant dissemination to the most aggressive subtype.

Full text

PDF
775

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arriagada R., Lê M. G., Mouriesse H., Fontaine F., Dewar J., Rochard F., Spielmann M., Lacour J., Tubiana M., Sarrazin D. Long-term effect of internal mammary chain treatment. Results of a multivariate analysis of 1195 patients with operable breast cancer and positive axillary nodes. Radiother Oncol. 1988 Mar;11(3):213–222. doi: 10.1016/0167-8140(88)90003-5. [DOI] [PubMed] [Google Scholar]
  2. Atkinson E. N., Brown B. W., Montague E. D. Tumor volume, nodal status, and metastasis in breast cancer in women. J Natl Cancer Inst. 1986 Feb;76(2):171–178. [PubMed] [Google Scholar]
  3. Bedwani R., Vana J., Rosner D., Schmitz R. L., Murphy G. P. Management and survival of female patients with "minimal" breast cancer: as observed in the long-term and short-term surveys of the American College of Surgeons. Cancer. 1981 Jun 15;47(12):2769–2778. doi: 10.1002/1097-0142(19810615)47:12<2769::aid-cncr2820471202>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  4. Brinkley D., Haybittle J. L. The curability of breast cancer. World J Surg. 1977 May;1(3):287–289. doi: 10.1007/BF01556839. [DOI] [PubMed] [Google Scholar]
  5. Contesso G., Rouéssé J., Petit J. Y., Mouriesse H. Les facteurs anatomo-pathologiques du pronostic des cancers du sein. Bull Cancer. 1977;64(4):525–536. [PubMed] [Google Scholar]
  6. Devitt J. E. The clinical stages of breast cancer--what do they mean? Can Med Assoc J. 1967 Nov 18;97(21):1257–1262. [PMC free article] [PubMed] [Google Scholar]
  7. Fisher B., Slack N. H. Number of lymph nodes examined and the prognosis of breast carcinoma. Surg Gynecol Obstet. 1970 Jul;131(1):79–88. [PubMed] [Google Scholar]
  8. Fisher E. R., Sass R., Fisher B. Pathologic findings from the National Surgical Adjuvant Project for Breast Cancers (protocol no. 4). X. Discriminants for tenth year treatment failure. Cancer. 1984 Feb 1;53(3 Suppl):712–723. doi: 10.1002/1097-0142(19840201)53:3+<712::aid-cncr2820531320>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  9. Handley R. S. Observations and thoughts on cancer of the breast. Proc R Soc Med. 1972 May;65(5):437–444. doi: 10.1177/003591577206500504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Koscielny S., Tubiana M., Lê M. G., Valleron A. J., Mouriesse H., Contesso G., Sarrazin D. Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer. 1984 Jun;49(6):709–715. doi: 10.1038/bjc.1984.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Koscielny S., Tubiana M., Valleron A. J. A simulation model of the natural history of human breast cancer. Br J Cancer. 1985 Oct;52(4):515–524. doi: 10.1038/bjc.1985.222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lacour J., Bucalossi P., Cacers E., Jacobelli G., Koszarowski T., Le M., Rumeau-Rouquette C., Veronesi U. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five-year results of an international cooperative study. Cancer. 1976 Jan;37(1):206–214. doi: 10.1002/1097-0142(197601)37:1<206::aid-cncr2820370130>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  13. Tabár L., Faberberg G., Day N. E., Holmberg L. What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer. 1987 May;55(5):547–551. doi: 10.1038/bjc.1987.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Tubiana M., Arriagada R., Sarrazin D. Human cancer natural history, radiation induced immunodepression and post-operative radiation therapy. Int J Radiat Oncol Biol Phys. 1986 Apr;12(4):477–485. doi: 10.1016/0360-3016(86)90055-6. [DOI] [PubMed] [Google Scholar]
  15. Tubiana M. Klaas Breur Medal lecture 1985. The growth and progression of human tumors: implications for management strategy. Radiother Oncol. 1986 Jul;6(3):167–184. doi: 10.1016/s0167-8140(86)80151-7. [DOI] [PubMed] [Google Scholar]
  16. Tubiana M., Koscielny S. Cell kinetics, growth rate and the natural history of breast cancer. The Heuson Memorial Lecture. Eur J Cancer Clin Oncol. 1988 Jan;24(1):9–14. doi: 10.1016/0277-5379(88)90170-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES